MicroRNAs and cardiac regeneration

Circulation Research

Volumn 116, Issue 10, 2015, Pages 1700-1711

  Hodgkinson, Conrad P ^a   Kang, Martin H ^a   Dal Pra, Sophie ^a   Mirotsou, Maria ^a   Dzau, Victor J ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac myocyte; microRNA; Regeneration; Stem cell; Transdifferentiation

Indexed keywords

MICRORNA; TRANSCRIPTION FACTOR;

CARDIAC REGENERATION; CARDIAC STEM CELL; CELL MATURATION; CELL TRANSDIFFERENTIATION; EMBRYONIC STEM CELL; FIBROBLAST; HEART DEVELOPMENT; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL LINEAGE; GENE EXPRESSION REGULATION; GENETICS; HEART DISEASE; METABOLISM; NUCLEAR REPROGRAMMING; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CELLULAR REPROGRAMMING; FIBROBLASTS; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; MICRORNAS; MYOCYTES, CARDIAC; PHENOTYPE; REGENERATION; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84937721395     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.304377     Document Type: Review

References (145)

1. Fan D, Takawale A, Lee J, Kassiri Z., Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012 5 15. doi: 10.1186/1755-1536-5-15
2. Dal-Pra S, Mirotsou M., Reprogramming approaches in cardiovascular regeneration. Curr Treat Options Cardiovasc Med 2014 16 327. doi: 10.1007/s11936-014-0327-0
3. Buckingham M, Meilhac S, Zaffran S., Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005; 6: 826-835. doi: 10.1038/nrg1710
4. Olson EN., Gene regulatory networks in the evolution and development of the heart. Science 2006; 313: 1922-1927. doi: 10.1126/science.1132292
5. Srivastava D., Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006; 126: 1037-1048. doi: 10.1016/j.cell.2006.09.003
6. Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN., Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012; 485: 599-604. doi: 10.1038/nature11139
7. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D., In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012; 485: 593-598. doi: 10.1038/nature11044
8. Protze S, Khattak S, Poulet C, Lindemann D, Tanaka EM, Ravens U., A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol 2012; 53: 323-332. doi: 10.1016/j.yjmcc.2012.04.010
9. Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ., MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 2012; 110: 1465-1473. doi: 10.1161/CIRCRESAHA.112.269035
10. Jayawardena T, Mirotsou M, Dzau VJ., Direct reprogramming of cardiac fibroblasts to cardiomyocytes using microRNAs. Methods Mol Biol 2014; 1150: 263-272. doi: 10.1007/978-1-4939-0512-6-18
11. Jayawardena TM, Finch EA, Zhang L, Zhang H, Hodgkinson CP, Pratt RE, Rosenberg PB, Mirotsou M, Dzau VJ., MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ Res 2015; 116: 418-424. doi: 10.1161/CIRCRESAHA.116.304510
12. Ghildiyal M, Zamore PD., Small silencing RNAs: an expanding universe. Nat Rev Genet 2009; 10: 94-108. doi: 10.1038/nrg2504
13. Schraivogel D, Meister G., Import routes and nuclear functions of Argonaute and other small RNA-silencing proteins. Trends Biochem Sci 2014; 39: 420-431. doi: 10.1016/j.tibs.2014.07.004
14. Kozomara A, Griffiths-Jones S., miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014 42 D68 D73. doi: 10.1093/nar/gkt1181
15. Friedman RC, Farh KK, Burge CB, Bartel DP., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105. doi: 10.1101/gr.082701.108
16. Ha M, Kim VN., Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014; 15: 509-524. doi: 10.1038/nrm3838
17. Coolen M, Bally-Cuif L., MicroRNAs in brain development and physiology. Curr Opin Neurobiol 2009; 19: 461-470. doi: 10.1016/j.conb.2009.09.006
18. Malizia AP, Wang DZ., MicroRNAs in cardiomyocyte development. Wiley Interdiscip Rev Syst Biol Med 2011; 3: 183-190. doi: 10.1002/wsbm.111
19. Ambros V., MicroRNAs and developmental timing. Curr Opin Genet Dev 2011; 21: 511-517. doi: 10.1016/j.gde.2011.04.003
20. Vidigal JA, Ventura A., Embryonic stem cell miRNAs and their roles in development and disease. Semin Cancer Biol 2012; 22: 428-436. doi: 10.1016/j.semcancer.2012.04.009
21. Sokol NS., Small temporal RNAs in animal development. Curr Opin Genet Dev 2012; 22: 368-373. doi: 10.1016/j.gde.2012.04.001
22. Kuppusamy KT, Sperber H, Ruohola-Baker H., MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. Curr Mol Med 2013 13 757 764
23. Wang XH., MicroRNA in myogenesis and muscle atrophy. Curr Opin Clin Nutr Metab Care 2013; 16: 258-266. doi: 10.1097/MCO.0b013e32835f81b9
24. Sun AX, Crabtree GR, Yoo AS., MicroRNAs: regulators of neuronal fate. Curr Opin Cell Biol 2013; 25: 215-221. doi: 10.1016/j.ceb.2012.12.007
25. Luo W, Nie Q, Zhang X., MicroRNAs involved in skeletal muscle differentiation. J Genet Genomics 2013; 40: 107-116. doi: 10.1016/j.jgg.2013.02.002
26. Cremisi F., MicroRNAs and cell fate in cortical and retinal development. Front Cell Neurosci 2013 7 141. doi: 10.3389/fncel.2013.00141
27. Turner ML, Schnorfeil FM, Brocker T., MicroRNAs regulate dendritic cell differentiation and function. J Immunol 2011; 187: 3911-3917. doi: 10.4049/jimmunol.1101137
28. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF., Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A 2006; 103: 8721-8726. doi: 10.1073/pnas.0602831103
29. Takaya T, Nishi H, Horie T, Ono K, Hasegawa K., Roles of microRNAs and myocardial cell differentiation. Prog Mol Biol Transl Sci 2012; 111: 139-152. doi: 10.1016/B978-0-12-398459-3.00006-X
30. Joladarashi D, Thandavarayan RA, Babu SS, Krishnamurthy P., Small engine, big power: microRNAs as regulators of cardiac diseases and regeneration. Int J Mol Sci 2014; 15: 15891-15911. doi: 10.3390/ijms150915891
31. Cai X, Hagedorn CH, Cullen BR., Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-1966. doi: 10.1261/rna.7135204
32. Gommans WM, Berezikov E., Controlling miRNA regulation in disease. Methods Mol Biol 2012; 822: 1-18. doi: 10.1007/978-1-61779-427-8-1
33. Ogata H, Audic S, Renesto-Audiffren P, Fournier PE, Barbe V, Samson D, Roux V, Cossart P, Weissenbach J, Claverie JM, Raoult D., Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 2001; 293: 2093-2098. doi: 10.1126/science.1061471
34. Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, Siomi H, Siomi MC., Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci U S A 2008; 105: 7964-7969. doi: 10.1073/pnas.0800334105
35. Iwasaki S, Kobayashi M, Yoda M, Sakaguchi Y, Katsuma S, Suzuki T, Tomari Y., Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Mol Cell 2010; 39: 292-299. doi: 10.1016/j.molcel.2010.05.015
36. Kawamata T, Seitz H, Tomari Y., Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol 2009; 16: 953-960. doi: 10.1038/nsmb.1630
37. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang DZ., Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci U S A 2008; 105: 2111-2116. doi: 10.1073/pnas.0710228105
38. da Costa Martins PA, Bourajjaj M, Gladka M, Kortland M, van Oort RJ, Pinto YM, Molkentin JD, De Windt LJ., Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 2008; 118: 1567-1576. doi: 10.1161/CIRCULATIONAHA.108.769984
39. Saxena A, Tabin CJ., miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation. Proc Natl Acad Sci U S A 2010; 107: 87-91. doi: 10.1073/pnas.0912870107
40. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D., Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007; 129: 303-317. doi: 10.1016/j.cell.2007.03.030
41. Zhao Y, Samal E, Srivastava D., Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005; 436: 214-220. doi: 10.1038/nature03817
42. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228-233. doi: 10.1038/ng1725
43. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN., An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci U S A 2007; 104: 20844-20849. doi: 10.1073/pnas.0710558105
44. Heidersbach A, Saxby C, Carver-Moore K, Huang Y, Ang YS, de Jong PJ, Ivey KN, Srivastava D., microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. Elife 2013 2 e01323. doi: 10.7554/eLife.01323
45. Wei Y, Peng S, Wu M, Sachidanandam R, Tu Z, Zhang S, Falce C, Sobie EA, Lebeche D, Zhao Y., Multifaceted roles of miR-1s in repressing the fetal gene program in the heart. Cell Res 2014; 24: 278-292. doi: 10.1038/cr.2014.12
46. Yin VP, Lepilina A, Smith A, Poss KD., Regulation of zebrafish heart regeneration by miR-133. Dev Biol 2012; 365: 319-327. doi: 10.1016/j.ydbio.2012.02.018
47. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN., microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008; 22: 3242-3254. doi: 10.1101/gad.1738708
48. Carè A, Catalucci D, Felicetti F, MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007; 13: 613-618. doi: 10.1038/nm1582
49. Li Q, Lin X, Yang X, Chang J., NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am J Physiol Heart Circ Physiol 2010 298 H1340 H1347. doi: 10.1152/ajpheart.00592.2009
50. Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF., Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 2010; 55: 946-952. doi: 10.1161/HYPERTENSIONAHA.109.139519
51. Wystub K, Besser J, Bachmann A, Boettger T, Braun T., miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development. PLoS Genet 2013 9 e1003793. doi: 10.1371/journal.pgen.1003793
52. Lompré AM, Nadal-Ginard B, Mahdavi V., Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem 1984 259 6437 6446
53. Chien KR., Genomic circuits and the integrative biology of cardiac diseases. Nature 2000; 407: 227-232. doi: 10.1038/35025196
54. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN., Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007; 316: 575-579. doi: 10.1126/science.1139089
55. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ., MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009; 119: 2772-2786. doi: 10.1172/JCI36154
56. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN., A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009; 17: 662-673. doi: 10.1016/j.devcel.2009.10.013
57. Morkin E., Control of cardiac myosin heavy chain gene expression. Microsc Res Tech 2000 50 522 531
58. Shieh JT, Huang Y, Gilmore J, Srivastava D., Elevated miR-499 levels blunt the cardiac stress response. PLoS One 2011 6 e19481. doi: 10.1371/journal.pone.0019481
59. Matkovich SJ, Hu Y, Eschenbacher WH, Dorn LE, Dorn GW II, Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ Res 2012; 111: 521-531. doi: 10.1161/CIRCRESAHA.112.265736
60. Laflamme MA, Murry CE., Heart regeneration. Nature 2011; 473: 326-335. doi: 10.1038/nature10147
61. Soonpaa MH, Field LJ., Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 1997 272 H220 H226
62. Hodgkinson CP, Dzau VJ., Conserved microRNA program as key to mammalian cardiac regeneration: insights from Zebrafish. Circ Res 2015; 116: 1109-1111. doi: 10.1161/CIRCRESAHA.115.305852
63. Poss KD, Wilson LG, Keating MT., Heart regeneration in zebrafish. Science 2002; 298: 2188-2190. doi: 10.1126/science.1077857
64. Jopling C, Boue S, Izpisua Belmonte JC., Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol 2011; 12: 79-89. doi: 10.1038/nrm3043
65. Aguirre A, Montserrat N, Zacchigna S, In vivo activation of a conserved microRNA program induces mammalian heart regeneration. Cell Stem Cell 2014; 15: 589-604. doi: 10.1016/j.stem.2014.10.003
66. Chen J, Huang ZP, Seok HY, Ding J, Kataoka M, Zhang Z, Hu X, Wang G, Lin Z, Wang S, Pu WT, Liao R, Wang DZ., mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 2013; 112: 1557-1566. doi: 10.1161/CIRCRESAHA.112.300658
67. Porrello ER, Johnson BA, Aurora AB, Simpson E, Nam YJ, Matkovich SJ, Dorn GW II, van Rooij E, Olson EN., MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res 2011; 109: 670-679. doi: 10.1161/CIRCRESAHA.111.248880
68. Porrello ER, Mahmoud AI, Simpson E, Johnson BA, Grinsfelder D, Canseco D, Mammen PP, Rothermel BA, Olson EN, Sadek HA., Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci U S A 2013; 110: 187-192. doi: 10.1073/pnas.1208863110
69. Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C, Latimer PA, Hare JM, Olson EN, van Rooij E., Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 2012; 110: 71-81. doi: 10.1161/CIRCRESAHA.111.244442
70. Cao X, Wang J, Wang Z, Du J, Yuan X, Huang W, Meng J, Gu H, Nie Y, Ji B, Hu S, Zheng Z., MicroRNA profiling during rat ventricular maturation: A role for miR-29a in regulating cardiomyocyte cell cycle re-entry. FEBS Lett 2013; 587: 1548-1555. doi: 10.1016/j.febslet.2013.01.075
71. Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M., Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012; 492: 376-381. doi: 10.1038/nature11739
72. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A., iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res 2009; 105: 648-656. doi: 10.1161/CIRCRESAHA.109.203109
73. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U., Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008; 118: 507-517. doi: 10.1161/CIRCULATIONAHA.108.778795
74. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A., Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009; 120: 408-416. doi: 10.1161/CIRCULATIONAHA.109.865154
75. Priori SG, Napolitano C, Di Pasquale E, Condorelli G., Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias. J Clin Invest 2013; 123: 84-91. doi: 10.1172/JCI62838
76. Yoshida Y, Yamanaka S., iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol 2011; 50: 327-332. doi: 10.1016/j.yjmcc.2010.10.026
77. Takahashi K, Yamanaka S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. doi: 10.1016/j.cell.2006.07.024
78. Hochedlinger K, Plath K., Epigenetic reprogramming and induced pluripotency. Development 2009; 136: 509-523. doi: 10.1242/dev.020867
79. Polo JM, Anderssen E, Walsh RM, A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012; 151: 1617-1632. doi: 10.1016/j.cell.2012.11.039
80. Miyoshi N, Ishii H, Nagano H, Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011; 8: 633-638. doi: 10.1016/j.stem.2011.05.001
81. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber PJ, Epstein JA, Morrisey EE., Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8: 376-388. doi: 10.1016/j.stem.2011.03.001
82. Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R, Blelloch R., Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 2011; 29: 443-448. doi: 10.1038/nbt.1862
83. Stead E, White J, Faast R, Conn S, Goldstone S, Rathjen J, Dhingra U, Rathjen P, Walker D, Dalton S., Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 2002; 21: 8320-8333. doi: 10.1038/sj.onc.1206015
84. Hanna J, Saha K, Pando B, van Zon J, Lengner CJ, Creyghton MP, van Oudenaarden A, Jaenisch R., Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009; 462: 595-601. doi: 10.1038/nature08592
85. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S., Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460: 1132-1135. doi: 10.1038/nature08235
86. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R., Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 2008; 40: 1478-1483. doi: 10.1038/ng.250
87. Tian Y, Zhang Y, Hurd L, Hannenhalli S, Liu F, Lu MM, Morrisey EE., Regulation of lung endoderm progenitor cell behavior by miR302/367. Development 2011; 138: 1235-1245. doi: 10.1242/dev.061762
88. Benetti R, Gonzalo S, Jaco I, Muñoz P, Gonzalez S, Schoeftner S, Murchison E, Andl T, Chen T, Klatt P, Li E, Serrano M, Millar S, Hannon G, Blasco MA., A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 2008; 15: 268-279. doi: 10.1038/nsmb.1399
89. Judson RL, Babiarz JE, Venere M, Blelloch R., Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 2009; 27: 459-461. doi: 10.1038/nbt.1535
90. Melton C, Judson RL, Blelloch R., Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010; 463: 621-626. doi: 10.1038/nature08725
91. Wang J, He Q, Han C, Gu H, Jin L, Li Q, Mei Y, Wu M., p53-facilitated miR-199a-3p regulates somatic cell reprogramming. Stem Cells 2012; 30: 1405-1413. doi: 10.1002/stem.1121
92. He L, He X, Lim LP, A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134. doi: 10.1038/nature05939
93. Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, Ozturk A, Hicks GG, Hannon GJ, He L., miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011; 13: 1353-1360. doi: 10.1038/ncb2366
94. Ye D, Wang G, Liu Y, Huang W, Wu M, Zhu S, Jia W, Deng AM, Liu H, Kang J., MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling. Stem Cells 2012; 30: 1645-1654. doi: 10.1002/stem.1149
95. Yang CS, Li Z, Rana TM., microRNAs modulate iPS cell generation. RNA 2011; 17: 1451-1460. doi: 10.1261/rna.2664111
96. Rosa A, Spagnoli FM, Brivanlou AH., The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell 2009; 16: 517-527. doi: 10.1016/j.devcel.2009.02.007
97. Liao B, Bao X, Liu L, MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J Biol Chem 2011; 286: 17359-17364. doi: 10.1074/jbc.C111.235960
98. Li Z, Yang CS, Nakashima K, Rana TM., Small RNA-mediated regulation of iPS cell generation. EMBO J 2011; 30: 823-834. doi: 10.1038/emboj.2011.2
99. Lipchina I, Elkabetz Y, Hafner M, Sheridan R, Mihailovic A, Tuschl T, Sander C, Studer L, Betel D., Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev 2011; 25: 2173-2186. doi: 10.1101/gad.17221311
100. Pfaff N, Fiedler J, Holzmann A, Schambach A, Moritz T, Cantz T, Thum T., miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2. EMBO Rep 2011; 12: 1153-1159. doi: 10.1038/embor.2011.176
101. Valcourt U, Thuault S, Pardali K, Heldin CH, Moustakas A., Functional role of Meox2 during the epithelial cytostatic response to TGF-beta. Mol Oncol 2007; 1: 55-71. doi: 10.1016/j.molonc.2007.02.002
102. Koche RP, Smith ZD, Adli M, Gu H, Ku M, Gnirke A, Bernstein BE, Meissner A., Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011; 8: 96-105. doi: 10.1016/j.stem.2010.12.001
103. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA., Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26: 795-797. doi: 10.1038/nbt1418
104. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A., Dissecting direct reprogramming through integrative genomic analysis. Nature 2008; 454: 49-55. doi: 10.1038/nature07056
105. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y, Archer TK., Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008; 28: 6426-6438. doi: 10.1128/MCB.00359-08
106. Lin SL, Chang DC, Lin CH, Ying SY, Leu D, Wu DT., Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 2011; 39: 1054-1065. doi: 10.1093/nar/gkq850
107. Anokye-Danso F, Snitow M, Morrisey EE., How microRNAs facilitate reprogramming to pluripotency. J Cell Sci 2012; 125: 4179-4187. doi: 10.1242/jcs.095968
108. Lu D, Davis MP, Abreu-Goodger C, Wang W, Campos LS, Siede J, Vigorito E, Skarnes WC, Dunham I, Enright AJ, Liu P., MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. PLoS One 2012 7 e40938. doi: 10.1371/journal.pone.0040938
109. Ivey KN, Muth A, Arnold J, King FW, Yeh RF, Fish JE, Hsiao EC, Schwartz RJ, Conklin BR, Bernstein HS, Srivastava D., MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008; 2: 219-229. doi: 10.1016/j.stem.2008.01.016
110. Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ, Baugh JJ, Jia F, Ghosh Z, Li RA, Butte AJ, Wu JC., Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet 2010; 3: 426-435. doi: 10.1161/CIRCGENETICS.109.934281
111. Takaya T, Ono K, Kawamura T, Takanabe R, Kaichi S, Morimoto T, Wada H, Kita T, Shimatsu A, Hasegawa K., MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 2009 73 1492 1497
112. Sunagawa Y, Morimoto T, Takaya T, Kaichi S, Wada H, Kawamura T, Fujita M, Shimatsu A, Kita T, Hasegawa K., Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes. J Biol Chem 2010; 285: 9556-9568. doi: 10.1074/jbc.M109.070458
113. Kwon C, Han Z, Olson EN, Srivastava D., MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci U S A 2005; 102: 18986-18991. doi: 10.1073/pnas.0509535102
114. Lu J, McKinsey TA, Zhang CL, Olson EN., Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 2000 6 233 244
115. Lu TY, Lin B, Li Y, Arora A, Han L, Cui C, Coronnello C, Sheng Y, Benos PV, Yang L., Overexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathways. J Mol Cell Cardiol 2013; 63: 146-154. doi: 10.1016/j.yjmcc.2013.07.019
116. Fu JD, Rushing SN, Lieu DK, Chan CW, Kong CW, Geng L, Wilson KD, Chiamvimonvat N, Boheler KR, Wu JC, Keller G, Hajjar RJ, Li RA., Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One 2011 6 e27417. doi: 10.1371/journal.pone.0027417
117. Glass C, Singla DK., MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am J Physiol Heart Circ Physiol 2011 301 H2038 H2049. doi: 10.1152/ajpheart.00271.2011
118. Wagh V, Pomorski A, Wilschut KJ, Piombo S, Bernstein HS., MicroRNA-363 negatively regulates the left ventricular determining transcription factor HAND1 in human embryonic stem cell-derived cardiomyocytes. Stem Cell Res Ther 2014 5 75. doi: 10.1186/scrt464
119. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D., miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008; 15: 272-284. doi: 10.1016/j.devcel.2008.07.008
120. Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D., microRNA-138 modulates cardiac patterning during embryonic development. Proc Natl Acad Sci U S A 2008; 105: 17830-17835. doi: 10.1073/pnas.0804673105
121. Townley-Tilson WH, Callis TE, Wang D., MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 2010; 42: 1252-1255. doi: 10.1016/j.biocel.2009.03.002
122. Gnecchi M, Zhang Z, Ni A, Dzau VJ., Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204-1219. doi: 10.1161/CIRCRESAHA.108.176826
123. Hodgkinson CP, Gomez JA, Payne AJ, Zhang L, Wang X, Dal-Pra S, Pratt RE, Dzau VJ., Abi3bp regulates cardiac progenitor cell proliferation and differentiation. Circ Res 2014; 115: 1007-1016. doi: 10.1161/CIRCRESAHA.115.304216
124. Georgiadis V, Knight RA, Jayasinghe SN, Stephanou A., Cardiac tissue engineering: renewing the arsenal for the battle against heart disease. Integr Biol (Camb) 2014; 6: 111-126. doi: 10.1039/c3ib40097b
125. Vierbuchen T, Wernig M., Molecular roadblocks for cellular reprogramming. Mol Cell 2012; 47: 827-838. doi: 10.1016/j.molcel.2012.09.008
126. Nam YJ, Song K, Luo X, Daniel E, Lambeth K, West K, Hill JA, DiMaio JM, Baker LA, Bassel-Duby R, Olson EN., Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A 2013; 110: 5588-5593. doi: 10.1073/pnas.1301019110
127. Muraoka N, Yamakawa H, Miyamoto K, MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J 2014; 33: 1565-1581. doi: 10.15252/embj.201387605
128. Leri A, Kajstura J, Anversa P., Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res 2011; 109: 941-961. doi: 10.1161/CIRCRESAHA.111.243154
129. Bolli R, Chugh AR, D'Amario D, Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011; 378: 1847-1857. doi: 10.1016/S0140-6736(11)61590-0
130. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E., Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012; 379: 895-904. doi: 10.1016/S0140-6736(12)60195-0
131. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ., MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler Thromb Vasc Biol 2010; 30: 859-868. doi: 10.1161/ATVBAHA.109.197434
132. Hosoda T, Zheng H, Cabral-da-Silva M, Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 2011; 123: 1287-1296. doi: 10.1161/CIRCULATIONAHA.110.982918
133. King IN, Qian L, Liang J, Huang Y, Shieh JT, Kwon C, Srivastava D., A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity. Dev Cell 2011; 20: 497-510. doi: 10.1016/j.devcel.2011.03.010
134. Qian L, Liu J, Bodmer R., Slit and Robo control cardiac cell polarity and morphogenesis. Curr Biol 2005; 15: 2271-2278. doi: 10.1016/j.cub.2005.10.037
135. Tousi SE, Soltani BM, Sadeghizadeh M, Mowla SJ, Parsi S, Soleimani M., Inhibitory effect of hsa-miR-590-5p on cardiosphere-derived stem cells differentiation through downregulation of TGFB signaling. J Cell Biochem 2015; 116: 179-191. doi: 10.1002/jcb.24957
136. Zhao J, Feng Y, Yan H, Chen Y, Wang J, Chua B, Stuart C, Yin D., β-arrestin2/miR-155/GSK3β regulates transition of 5'-azacytizine-induced Sca-1-positive cells to cardiomyocytes. J Cell Mol Med 2014; 18: 1562-1570. doi: 10.1111/jcmm.12339
137. Sirish P, López JE, Li N, Wong A, Timofeyev V, Young JN, Majdi M, Li RA, Chen HS, Chiamvimonvat N., MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. J Mol Cell Cardiol 2012; 52: 264-272. doi: 10.1016/j.yjmcc.2011.10.012
138. Liang D, Zhen L, Yuan T, miR-10a regulates proliferation of human cardiomyocyte progenitor cells by targeting GATA6. PLoS One 2014 9 e103097. doi: 10.1371/journal.pone.0103097
139. Yang X, Marcucci K, Anguela X, Couto LB., Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection. Mol Ther 2013; 21: 588-601. doi: 10.1038/mt.2012.247
140. van Rooij E, Olson EN., MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012; 11: 860-872. doi: 10.1038/nrd3864
141. Kotterman MA, Schaffer DV., Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet 2014; 15: 445-451. doi: 10.1038/nrg3742
142. Tilemann L, Ishikawa K, Weber T, Hajjar RJ., Gene therapy for heart failure. Circ Res 2012; 110: 777-793. doi: 10.1161/CIRCRESAHA.111.252981
143. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T., IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 2000; 1: 376-382. doi: 10.1006/mthe.2000.0050
144. Thum T, Gross C, Fiedler J, MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-984. doi: 10.1038/nature07511
145. Hornstein E, Shomron N., Canalization of development by microRNAs. Nat Genet 2006; 38 (suppl) S20-S24. doi: 10.1038/ng1803